Akoustis™ Chief Materials Scientist to Present at IWN 2016
Oct 04, 2016 11:01 am UTC| Business
Charlotte, N.C., Oct. 04, 2016 -- Akoustis Technologies, Inc. (OTCQB: AKTS) (“Akoustis” or the “Company”), a manufacturer of innovative BulkONE™ bulk acoustic wave (BAW) high-band RF filters for mobile wireless,...
Akoustis™ Chief Materials Scientist to Present at IWN 2016
Oct 04, 2016 11:01 am UTC| Business
Charlotte, N.C., Oct. 04, 2016 -- Akoustis Technologies, Inc. (OTCQB: AKTS) (“Akoustis” or the “Company”), a manufacturer of innovative BulkONE™ bulk acoustic wave (BAW) high-band RF filters for mobile wireless,...
AGTC to Present at Upcoming Scientific Conferences
Oct 04, 2016 11:01 am UTC| Business
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Oct. 04, 2016 -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a clinical stage biotechnology company developing adeno-associated virus (AAV)-based gene therapies for...
AGTC to Present at Upcoming Scientific Conferences
Oct 04, 2016 11:01 am UTC| Business
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Oct. 04, 2016 -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a clinical stage biotechnology company developing adeno-associated virus (AAV)-based gene therapies for...
Phase 3 trial of Medidur™ in Posterior Segment Uveitis Meets Enrollment Target
Oct 04, 2016 11:01 am UTC| Business
Study is the Second of Two Ongoing Phase 3 Trials in SupportOf Product Registration in the US EU Filing Remains on Track for 1Q2017 Filing WATERTOWN, Mass., Oct. 04, 2016 -- pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a...
Phase 3 trial of Medidur™ in Posterior Segment Uveitis Meets Enrollment Target
Oct 04, 2016 11:01 am UTC| Business
Study is the Second of Two Ongoing Phase 3 Trials in SupportOf Product Registration in the US EU Filing Remains on Track for 1Q2017 Filing WATERTOWN, Mass., Oct. 04, 2016 -- pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a...
Oct 04, 2016 11:00 am UTC| Business
Sarepta and Summit collaborate to advance the development of novel therapies for patients with Duchenne muscular dystrophySummit receives $40 million upfront, with potential future ezutromid-related milestone payments...
FxWirePro- Major Economic events for the day